The uses and limitations of whole-body magnetic resonance imaging;Übersichtsarbeit möglichkeiten und grenzen der ganzkörper-MRT

Deutsches Arzteblatt

Volumn 107, Issue 22, 2010, Pages 383-389

  Schmidt, Gerwin ^a   Dinter, Dietmar ^b   Reiser, Maximilian F ^a   Schoenberg, Stefan O ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW CANCER; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL DECISION MAKING; DIAGNOSTIC ACCURACY; FALSE POSITIVE RESULT; HUMAN; MULTIPLE MYELOMA; PATHOLOGICAL ANATOMY; REVIEW; SURVIVAL RATE; WHOLE BODY MRI; ARTHRITIS, RHEUMATOID; CHONDROSARCOMA; DEVICES; DIABETIC ANGIOPATHIES; DISEASE COURSE; EARLY DIAGNOSIS; EQUIPMENT DESIGN; IMAGE PROCESSING; NEOPLASMS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SENSITIVITY AND SPECIFICITY; WHOLE BODY IMAGING;

ARTHRITIS, RHEUMATOID; CHONDROSARCOMA; DIABETIC ANGIOPATHIES; DISEASE PROGRESSION; EARLY DETECTION OF CANCER; EARLY DIAGNOSIS; EQUIPMENT DESIGN; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; NEOPLASMS; SENSITIVITY AND SPECIFICITY; WHOLE BODY IMAGING;

EID: 77955497820     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2010.0383     Document Type: Review

References (23)

1. Schmidt GP, Wintersperger B, Graser A, Baur-Melnyk A, Reiser MF, Schoenberg SO: High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative study. Invest Radiol 2007; 449-59.
2. Kruger DG, Riederer SJ, Grimm RC, Rossman PJ: Continuously moving table data acquisition method for long FOV contrast-enhanced MRA and whole-body MRI. Magn Reson Med 2002; 47: 224-31.
3. Goehde SC, Hunold P, Vogt FM, et al.: Full-body cardiovascular and tumor MRI for early detection of disease: feasibility and initial experience in 298 subjects. AJR 2005; 184: 598-611.
4. Kramer H, Michaely K, Nikolaou K, Reiser MF, Schoenberg SO: State of the art cardiovascular imaging with parallel imaging tech - niques on a whole body MR scanner: experience in more than 200 individuals. Eur Radiol 2006; 16 (S): 232.
5. Baumgart D, Egelhof T: Präventives Ganzkörperscreening unter Einbeziehung moderner Bildgebung mit Hilfe der Magnetresonanztomographie. Herz 2007; 32: 387-94.
6. American Joint Committee on Cancer: AJCC Cancer Staging Manual (6th edition). 2002; New York: Springer.
7. Plathow C, Walz M, Lichy MP, et al.: Kostenüberlegungen zur Ganzkörper-MRT und PET-CT im Rahmen des onkologischen Stagings Radiologe 2008; 48: 384-96.
8. Goyen M, Schlemmer HP: Ganzkörper-MRT - diagnostische Stra - tegie der Zukunft? Radiologe 2004; 47: 904-14.
9. Schmidt GP, Baur-Melnyk A, Herzog P, et al.: High-resolution wholebody MRI tumor staging with the use of parallel imaging versus dual modality PET-CT: experience on a 32-channel system. Invest Radiol 2005; 40: 743-53.
10. Takahara T, Imay Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M: Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004: 22: 275-82.
11. Rao SX, Zeng MS, Chen CZ, et al.: The value of diffusion-weighted imaging in combination with T2-weighted imaging for rectal cancer detection. Eur J Radiol 2008; 65: 299-303.
12. Steinborn M, Tiling R, Heuck A, Brügel M, Stäbler A, Reiser M: Dia gnostik der Metastasierung im Knochenmark mittels MRT. Der Radiologe 2000; 40: 826-34.
13. Semelka RC, Worawattanakul S, Kelekis NL, et al.: Liver lesion detection, characterization, and effect on patient managment: comparison of single-phase spiral CT and current MR techniques. J Magn Reson Imaging 1997; 7: 1040-7.
14. Antoch G, Vogt FM, Freudenberg LS, et al.: Whole-body dualmodality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 2003; 290: 3199-206.
15. Schmidt GP, Baur-Melnyk A, Haug A, et al.: Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer. Eur Radiol 2009; 19: 1366-78.
16. Schmidt GP, Baur-Melnyk A, Haug A, et al.: Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT. Eur J Radiol 2008; 65: 47-58.
17. Schlemmer HP, Schäfer J, Pfannenberg C, Radny P, Korchidi S, Müller-Horvat C: Fast whole-body assessment of metastatic disease using a novel magnetic resonance imaging system: initial experiences. Invest Radiol 2005; 40: 64-71.
18. Ghanem N, Lohrmann C, Engelhardt M, et al.: Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey. Eur Radiol 2006; 16: 1005-14.
19. Baur-Melnyk A, Buhmann S, Becker C, et al.: Whole-body MRI versus whole-body MDCT for staging of multiple myeloma. Am J Roentgenol 2008; 190: 1097-104.
20. Baur A, Stäbler A, Nagel D, et al.: Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon? Cancer 2002; 95: 1334-45.
21. Dinter DJ, Neff WK, Klaus J: Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy. Ann Hematol 2009; 88: 457-64.
22. Weckbach S, Michaely HJ, Friedrich D, Schewe S, Reiser MF, Glaser C: Whole body MR Imaging in psoriatic arthritis: development of an imaging protocol and evaluation in 25 patients. Eur Radiol 2007; (Suppl.1) 17: 139.
23. Weckbach S, Findeisen HM, Schoenberg SO, et al.: Systemic cardiovascular complications in patients with long-standing diabetes mellitus: comprehensive assessment with whole-body magnetic resonance imaging/magnetic resonance angiography. Invest Radiol 2009; 44: 242-50.